Cryopreserved clinical-grade human embryonic stem cell-derived dopaminergic progenitors function in Parkinson's disease models
Life Sciences · 2023
DOI: 10.1016/j.lfs.2023.121990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2023. Verfasst von Somayeh Naderi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology, School of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran; …. Hauptthemen laut MEDLINE: Parkinson Disease, Human Embryonic Stem Cells, Pluripotent Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
AIM: Parkinson's Disease (PD) is a common age-related neurodegenerative disorder with a rising prevalence. Human pluripotent stem cells have emerged as the most promising source of cells for midbrain dopaminergic (mDA) neuron replacement in PD. This study aimed to generate transplantable mDA progenitors for treatment of PD. MATERIALS AND METHODS: Here, we optimized and fine-tuned a differentiation protocol using a combination of small molecules and growth factors to induce mDA progenitors to comply with good manufacturing practice (GMP) guidelines based on our clinical-grade human embryonic stem cell (hESC) line. KEY FINDINGS: The resulting mDA progenitors demonstrated robust differentiation and functional properties in vitro. Moreover, cryopreserved mDA progenitors were transplanted into 6-hydroxydopamine-lesioned rats, leading to functional recovery. SIGNIFICANCE: We demonstrate that our optimized protocol using a clinical hESC line is suitable for generating clinical-grade mDA progenitors and provides the ground work for future translational applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Developmental Biology, School of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran; Department of Stem Cells and Developmental Biology, Cell Science Resea…
- Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Department of Brain and Cognitive Sciences, Cell Science Resea…
- Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
- Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Advanced Therapy Medicinal Product Technology Development Cent…
- Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Zitieren
APA
Naderi, S., Shiri, Z., Zarei-Kheirabadi, M., Mollamohammadi, S., Hosseini, P., Rahimi, G., Moradmand, A., Samadian, A., Shojaei, A., Yeganeh, M., Mousavi, S. A., Badri, M., Taei, A., Hassani, S. N., & Baharvand, H. (2023). Cryopreserved clinical-grade human embryonic stem cell-derived dopaminergic progenitors function in Parkinson's disease models. Life Sciences. https://doi.org/10.1016/j.lfs.2023.121990
Vancouver
Naderi S, Shiri Z, Zarei-Kheirabadi M, Mollamohammadi S, Hosseini P, Rahimi G, et al. Cryopreserved clinical-grade human embryonic stem cell-derived dopaminergic progenitors function in Parkinson's disease models. Life Sciences. 2023. doi:10.1016/j.lfs.2023.121990
BibTeX
@article{Naderi2023,
author = {Naderi, Somayeh and Shiri, Zahra and Zarei-Kheirabadi, Masoumeh and Mollamohammadi, Sepideh and Hosseini, Parastoo and Rahimi, Golnoosh and Moradmand, Azadeh and Samadian, Azam and Shojaei, Amir and Yeganeh, Meghdad and Mousavi, Seyed Ahmad and Badri, Motahare and Taei, Adeleh and Hassani, Seyedeh-Nafiseh and Baharvand, Hossein},
title = {Cryopreserved clinical-grade human embryonic stem cell-derived dopaminergic progenitors function in Parkinson's disease models},
journal = {Life Sciences},
year = {2023},
doi = {10.1016/j.lfs.2023.121990}
}
EUVIMED